0001209191-20-052267.txt : 20200928
0001209191-20-052267.hdr.sgml : 20200928
20200928193702
ACCESSION NUMBER: 0001209191-20-052267
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200924
FILED AS OF DATE: 20200928
DATE AS OF CHANGE: 20200928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Sandor Victor
CENTRAL INDEX KEY: 0001620368
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39527
FILM NUMBER: 201205695
MAIL ADDRESS:
STREET 1: C/O ARRAY BIOPHARMA INC.
STREET 2: 3200 WALNUT STREET
CITY: BOULDER
STATE: CO
ZIP: 80301
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Prelude Therapeutics Inc
CENTRAL INDEX KEY: 0001678660
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811384762
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0331
BUSINESS ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
BUSINESS PHONE: (302) 547-3768
MAIL ADDRESS:
STREET 1: 200 POWDER MILL ROAD
CITY: WILMINGTON
STATE: DE
ZIP: 19803
FORMER COMPANY:
FORMER CONFORMED NAME: Prelude Therapeutics Inc.
DATE OF NAME CHANGE: 20160630
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-09-24
0
0001678660
Prelude Therapeutics Inc
PRLD
0001620368
Sandor Victor
C/O PRELUDE THERAPEUTICS INCORPORATED
200 POWDER MILL ROAD
WILMINGTON
DE
19801
1
0
0
0
Director Stock Option (right to buy)
19.00
2020-09-24
4
A
0
3458
0.00
A
2030-09-23
Common Stock
3458
3458
D
The stock option vests as of 1/36 of the total shares monthly beginning on September 24, 2020 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
/s/ Brian Piper, as Attorney-in-Fact for Victor Sandor
2020-09-28